307 related articles for article (PubMed ID: 3723189)
41. [Scintigraphy with 131I-metaiodobenzylguanidine in the differential diagnosis of pheochromocytoma].
Cerasola G; Marozzi P; Morici ML; Cottone S; D'Ignoto G; Grasso L; Bompiani GD
Recenti Prog Med; 1985 Mar; 76(3):143-8. PubMed ID: 4012017
[No Abstract] [Full Text] [Related]
42. [Clinical evaluation of 131I-MIBG (meta-iodobenzylguanidine) imaging in suspected pheochromocytoma].
Nakabeppu Y; Nakajo M; Iwashita S; Yonekura R; Yoshimura H; Shimabukuro K; Shinohara S; Sakata H
Kaku Igaku; 1989 Nov; 26(11):1445-51. PubMed ID: 2615031
[No Abstract] [Full Text] [Related]
43. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
Nakajo M; Shinohara S
Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
[No Abstract] [Full Text] [Related]
44. Scintigraphic localization of a disseminated malignant pheochromocytoma with the use of 131I-meta-iodobenzylguanidine.
Troncone L; Maini CL; De Rosa G; Corsello SM; Rufini V; Mattei O; Bonifazi N
Eur J Nucl Med; 1984; 9(9):429-32. PubMed ID: 6499877
[TBL] [Abstract][Full Text] [Related]
45. [A case of paraganglioma diagnosed by 131I-metaiodobenzyl guanidine (MIBG) scintigraphy].
Kubo S; Imamura T; Kinoshita S; Tagawa H; Fukui J; Koga H; Hara K; Hirayu S; Izumi M; Nagataki S
Nihon Naika Gakkai Zasshi; 1984 Aug; 73(8):1201-8. PubMed ID: 6512353
[No Abstract] [Full Text] [Related]
46. Meta-iodobenzylguanidine in children.
Gelfand MJ
Semin Nucl Med; 1993 Jul; 23(3):231-42. PubMed ID: 8378796
[TBL] [Abstract][Full Text] [Related]
47. [131I-metaiodobenzylguanidine: diagnostic and therapeutic value].
Simó R; Mesa J
Med Clin (Barc); 1986 Nov; 87(14):597-601. PubMed ID: 3784681
[No Abstract] [Full Text] [Related]
48. Imaging of adrenal medulla with I-131-mIBG. Clinical experience in 208 cases.
Zhu RS; Ma JX; Xu JQ
Chin Med J (Engl); 1988 Jul; 101(7):513-6. PubMed ID: 3147850
[No Abstract] [Full Text] [Related]
49. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.
Nakajo M; Shapiro B; Copp J; Kalff V; Gross MD; Sisson JC; Beierwaltes WH
J Nucl Med; 1983 Aug; 24(8):672-82. PubMed ID: 6135764
[TBL] [Abstract][Full Text] [Related]
50. A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.
Cecchin D; Lumachi F; Marzola MC; Opocher G; Scaroni C; Zucchetta P; Mantero F; Bui F
Endocr Relat Cancer; 2006 Jun; 13(2):525-33. PubMed ID: 16728579
[TBL] [Abstract][Full Text] [Related]
51. Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison.
Bomanji J; Levison DA; Flatman WD; Horne T; Bouloux PM; Ross G; Britton KE; Besser GM
J Nucl Med; 1987 Jun; 28(6):973-8. PubMed ID: 3585505
[TBL] [Abstract][Full Text] [Related]
52. Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy.
Lynn MD; Shapiro B; Sisson JC; Beierwaltes WH; Meyers LJ; Ackerman R; Mangner TJ
Radiology; 1985 Jun; 155(3):789-92. PubMed ID: 4001380
[TBL] [Abstract][Full Text] [Related]
53. Current concepts on the diagnostic use of MIBG in children.
Shulkin BL; Shapiro B
J Nucl Med; 1998 Apr; 39(4):679-88. PubMed ID: 9544682
[TBL] [Abstract][Full Text] [Related]
54. False diagnosis of bilateral phaeochromocytoma by iodine-131-labelled meta-iodobenzylguanidine (MIBG).
Brown MJ; Fuller RW; Lavender JP
Lancet; 1984 Jan; 1(8367):56-7. PubMed ID: 6140389
[No Abstract] [Full Text] [Related]
55. Localization of a pheochromocytoma using I-123 MIBG adrenal scintigraphy.
Shirkare S; Kuwert T; Weckesser M; Czech N; Langen KJ; Muller-Gartner HW
J Postgrad Med; 1994; 40(2):85-7. PubMed ID: 8737560
[TBL] [Abstract][Full Text] [Related]
56. [The usefulness of I-131 MIBG scintigraphy in extra-adrenal lesions of pheochromocytoma].
Kubo A; Nakayama T; Nishiguchi I; Hashimoto T; Kunieda E; Hashimoto S
Rinsho Hoshasen; 1988 Feb; 33(2):257-63. PubMed ID: 3385949
[No Abstract] [Full Text] [Related]
57. [131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters].
Maurelli L; Cuocolo A; Lastoria S; Brunetti A; Maurea S; Lembo G; Klain M; Caracò C; Salvatore M
Radiol Med; 1991 Dec; 82(6):839-43. PubMed ID: 1788441
[TBL] [Abstract][Full Text] [Related]
58. [131I-MIBG scintigraphy for the detection of metastatic lesions from malignant pheochromocytoma--comparison of 131I-MIBG scintigraphy with 99mTc-MDP bone scintigraphy in detecting bone metastases].
Ozawa N; Imaeda T; Seki M; Koike S
Kaku Igaku; 1988 Jan; 25(1):97-103. PubMed ID: 3373813
[No Abstract] [Full Text] [Related]
59. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy.
Furuta N; Kiyota H; Yoshigoe F; Hasegawa N; Ohishi Y
Int J Urol; 1999 Mar; 6(3):119-24. PubMed ID: 10226821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
